Insiders Updates
An Analysis of Heron Therapeutics Inc (HRTX)’s Potential Price Growth
Heron Therapeutics Inc’s recent filing unveils that its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58
Menu
Heron Therapeutics Inc’s recent filing unveils that its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58
Heron Therapeutics Inc’s recently made public that its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58
In a filing, Heron Therapeutics Inc revealed its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58
In a filing, Heron Therapeutics Inc revealed its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58
In a filing, Heron Therapeutics Inc revealed its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Heron Therapeutics Inc’s filing revealed that its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Heron Therapeutics Inc’s recent filing unveils that its 10% Owner Rubric Capital Management LP acquired Company’s shares for reported $3.58